WASHINGTON (Reuters) - U.S. health regulators said on Friday they have ordered the detention of all imported supplies of heparin blood-thinner products so they can be tested for possible contamination ...
Heparin, a naturally occurring glycosaminoglycan, is widely used as an anticoagulant in clinical settings, yet its complex polydisperse structure poses significant challenges for accurate detection ...
Dec. 19, 2016 9:43 AM ETTNF Pharmaceuticals, Inc. (TNFA) StockBy: SA News Team ...
Akers to supply its screening test for allergic reaction to blood thinner Heparin. Akers Biosciences Inc. said Wednesday it has received an initial purchase order, valued at $1 million, for its rapid ...
Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results